TransMedics Group, Inc.TMDXNASDAQ

111.97-117.90

52-Week Range62-156

62.23Current 112.08156.00

Want to monitor TMDX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

Manufacturing

Surgical and Medical Instrument Manufacturing

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Newsmax Appoints David Evans to Board of Directors

METC DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ramaco Resources, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - METC

Iren SpA (IRDEY) Q4 2025 Earnings Call Transcript

ROSEN, LEADING TRIAL COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENPH

Hyundai recalls 58,000 Palisade SUVs in South Korea due to automatic seat problem

D-BOX Technologies Announces Normal Course Issuer Bid

Super Micro Computer: More Issues Arise

From LNG & KMI to OKLO & CEG: Joe Rinaldi Offers Energy Bull Cases

Monday's Final Takeaways: Gold & AI Memory Chips Left Out of Market Rally

Weatherford Announces First-Quarter 2026 Conference Call

Timbercreek Financial Declares March 2026 Dividend

Northpointe Bancshares, Inc. Announces Date of First Quarter 2026 Earnings Release and Conference Call

Centerra Gold Files Annual Report on Form 40-F

Parkit Announces Normal Course Issuer Bid

Hormel Foods Corporation Declares Quarterly Dividend

Perimeter Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 31st; Provides Corporate Update

DeFi Technologies Provides Update on Timing of Annual Filings

XCF Global CEO Highlights Renewable Energy Security as Cornerstone of Scaling Sustainable Aviation Fuel at Advanced Bioeconomy Leadership Conference, ABLC2026

Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results

Lument Finance Trust Reports 2025 Results

About